English
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#drugdevelopment search results

CPathInstitute's profile picture. C-Path leads collaborations that accelerate drug development, advancing better treatment for people worldwide.
Critical Path Institute (C-Path)
 @CPathInstitute
4 m

In 2025, C-Path proudly celebrates 20 years of impact. Take a look back at the highlights and the incredible individuals who made it all possible. Here's to the next chapter of innovation! f.mtr.cool/lglzgvzfjq #CPath20Years #DrugDevelopment #Collaboration

0
0
0
0
6
NeulandLabs's profile picture. Neuland Labs is a leading manufacturer of active pharmaceutical ingredients (APIs) and a chemistry solutions provider to the pharmaceutical industry.
NeulandLabs
 @NeulandLabs
Oct 27

Every stage of drug development benefits from the right expertise. Explore how choosing between a CDMO, CMO, or CRO can define your project’s progress in our new blog. Read the full article here: hubs.la/Q03Q9lx-0 #NeulandLabs #CDMO #DrugDevelopment #Outsourcing

NeulandLabs's tweet image. Every stage of drug development benefits from the right expertise. Explore how choosing between a CDMO, CMO, or CRO can define your project’s progress in our new blog. Read the full article here: hubs.la/Q03Q9lx-0 #NeulandLabs #CDMO #DrugDevelopment #Outsourcing
1
0
4
0
316
tmprowell's profile picture. Oncologist serving people w/ #cancer in #MedEd #SciComm & #bcsm. Past ASCO Ed Chair. Cofounder @HCWvsHunger. #LongCovid. Team hope/good trouble/go high. No FCOI
Tatiana Prowell, MD
 @tmprowell
Nov 1

❗️Prediction for #DrugDevelopment: Companies that wait to work on #LongCovid will regret it. This is a large & growing population (w/ very organized/engaged patient #advocacy, major unmet need, & no approved agents) whose disability has huge societal economic impact. Don’t wait.

2
4
14
0
2K
JiaJennyLiu's profile picture. Early Phase Trials Medical Onc Translational Researcher @kinghorncancer SVH Sydney @CMRI Senior Lecturer @UNSW. MOGA Exec. #PrecisionMedicine #drugdevelopment
Jia (Jenny) Liu MD PhD
 @JiaJennyLiu
Oct 27

Totally agree @curijoey - taking a post-#ESMO25 recovery pause in your beautiful home country 🇮🇹 🍷🫒⛪️ at the moment… before return to #drugdevelopment rat race! 🇦🇺

JiaJennyLiu's tweet image. Totally agree @curijoey - taking a post-#ESMO25 recovery pause in your beautiful home country 🇮🇹 🍷🫒⛪️ at the moment… before return to #drugdevelopment rat race! 🇦🇺
JiaJennyLiu's tweet image. Totally agree @curijoey - taking a post-#ESMO25 recovery pause in your beautiful home country 🇮🇹 🍷🫒⛪️ at the moment… before return to #drugdevelopment rat race! 🇦🇺
curijoey's profile picture. Giuseppe Curigliano, MD, PhD, Professor at University of Milan and Head of Phase I Division at IEO, ESMO Open EiC, Tweets are my own
G Curigliano MD PhD
 @curijoey
Oct 26

Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿

curijoey's tweet image. Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿
curijoey's tweet image. Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿
curijoey's tweet image. Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿
curijoey's tweet image. Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿
4
6
146
2
8K
1
1
8
0
2K
DrMirallas's profile picture. Fellow @MDAndersonNews | Medical Oncol, Drug Develop+🫁 23-25 @VHIO | Med Oncology 18-23 @vallhebron | Vocal Junta 21-25 @COMBarcelona Profesor 18-25 @SalutUIC
Oriol Mirallas MD
 @DrMirallas
Oct 15

#ESMO2025 Berlin is SOON here 🇩🇪 🚀 My #Top10 for #drugdevelopment @myESMO Interesting new drugs coming out 🙌🏽 🧫 CAR-T 💉 ADC 🦠 Vaccines 🧪 New#ICIs 🎯 #therapies @ASCO @_SEOM @VHIO @MDAndersonNews @OncBrothers 🌍 Follow: #OncoAlertAF @OncoAlert What do you think? 💭👇🏽

DrMirallas's tweet image. #ESMO2025 Berlin is SOON here 🇩🇪 🚀 My #Top10 for #drugdevelopment @myESMO Interesting new drugs coming out 🙌🏽 🧫 CAR-T 💉 ADC 🦠 Vaccines 🧪 New#ICIs 🎯 #therapies @ASCO @_SEOM @VHIO @MDAndersonNews @OncBrothers 🌍 Follow: #OncoAlertAF @OncoAlert What do you think? 💭👇🏽
0
23
73
26
8K
FinQuota's profile picture. Stay ahead in the world of finance with FinQuota. #Finance #Investing #MarketAnalysis #Stocks
FinQuota
@FinQuota
Oct 6

Is CRBP stock just practicing its yoga poses with all these ups and downs? Source: finquota.com/CRBP/ #StockMarket #DrugDevelopment #ClinicalTrials #NYSE #stock #stocks

FinQuota's tweet image. Is CRBP stock just practicing its yoga poses with all these ups and downs? Source: finquota.com/CRBP/ #StockMarket #DrugDevelopment #ClinicalTrials #NYSE #stock #stocks
0
2
7
0
49
ncats_nih_gov's profile picture. Official account. https://t.co/E0jyoPAqWA https://t.co/5jpXb0jIER engagement ≠ endorsement
NCATS
@ncats_nih_gov
Sep 23

For over 10 years, we have made #DrugDiscovery & development steps faster & more predictable. Using what we’ve learned, we create educational resources to share this information with the #TranslationalScience community. To improve understanding of the complex #DrugDevelopment &…

ncats_nih_gov's tweet image. For over 10 years, we have made #DrugDiscovery & development steps faster & more predictable. Using what we’ve learned, we create educational resources to share this information with the #TranslationalScience community. To improve understanding of the complex #DrugDevelopment &…
ncats_nih_gov's tweet image. For over 10 years, we have made #DrugDiscovery & development steps faster & more predictable. Using what we’ve learned, we create educational resources to share this information with the #TranslationalScience community. To improve understanding of the complex #DrugDevelopment &…
0
2
6
1
542
editorNRTimes's profile picture. NR Times, the neurorehabilitation platform covering brain and spinal injuries and neuro conditions from every angle. Sign-up & subscribe online.
Neuro Rehab Times
@editorNRTimes
Oct 27

BioNxt has launched a 15-day dosing optimisation study for its sublingual multiple sclerosis (MS) drug, marking the final step before human bioequivalence testing planned for early 2026. 🔗 Full story: buff.ly/gPjwCF7 #MultipleSclerosis #NeuroResearch #DrugDevelopment…

editorNRTimes's tweet image. BioNxt has launched a 15-day dosing optimisation study for its sublingual multiple sclerosis (MS) drug, marking the final step before human bioequivalence testing planned for early 2026. 🔗 Full story: buff.ly/gPjwCF7 #MultipleSclerosis #NeuroResearch #DrugDevelopment…
0
0
2
0
99
demy_sara's profile picture. Founder & CEO Demy-Colton Member @SpringboardEnt Council. Creator of #BiotechShowcase #GlobalBiotechCEOSummit #BioFuture #LifeSciences events.
Sara Jane Demy
 @demy_sara
Oct 15

#BioFuture2025 Day 3 spotlighted innovation at every level, from The New Policy Landscape to #AI in #DrugDevelopment. Thank you to our speakers, sponsors, and attendees for an incredible close to this year’s conference. See you in 2026! 💫

demy_sara's tweet image. #BioFuture2025 Day 3 spotlighted innovation at every level, from The New Policy Landscape to #AI in #DrugDevelopment. Thank you to our speakers, sponsors, and attendees for an incredible close to this year’s conference. See you in 2026! 💫
demy_sara's tweet image. #BioFuture2025 Day 3 spotlighted innovation at every level, from The New Policy Landscape to #AI in #DrugDevelopment. Thank you to our speakers, sponsors, and attendees for an incredible close to this year’s conference. See you in 2026! 💫
demy_sara's tweet image. #BioFuture2025 Day 3 spotlighted innovation at every level, from The New Policy Landscape to #AI in #DrugDevelopment. Thank you to our speakers, sponsors, and attendees for an incredible close to this year’s conference. See you in 2026! 💫
0
0
1
0
25
Certara's profile picture. Accelerating medicines to patients with biosimulation, technology and services.
Certara
 @Certara
Oct 4

Pharmacology Jargon Simplified: Steady-State Occurs when drug input = drug elimination, giving consistent therapeutic levels. Key for chronic conditions, predictable effects & dosing optimization. Learn more 👉 ow.ly/KP4550WZEOq #Pharmacology #DrugDevelopment

Certara's tweet image. Pharmacology Jargon Simplified: Steady-State Occurs when drug input = drug elimination, giving consistent therapeutic levels. Key for chronic conditions, predictable effects & dosing optimization. Learn more 👉 ow.ly/KP4550WZEOq #Pharmacology #DrugDevelopment
0
0
1
0
56
DrMirallas's profile picture. Fellow @MDAndersonNews | Medical Oncol, Drug Develop+🫁 23-25 @VHIO | Med Oncology 18-23 @vallhebron | Vocal Junta 21-25 @COMBarcelona Profesor 18-25 @SalutUIC
Oriol Mirallas MD
 @DrMirallas
Oct 17

#ESMO25 #drugdevelopment 👉🏽 Botensilimab (CTLA4) + Balstilimab (PD1) 🗣️ Dr. Gordon 👥 Pantumor cold tumors and PD1 r/r ✅ ORR 17% ✅ 411 patients ✅ Durable responses in 🥶tumors ☣️ 10% =>G3 colitis @OncoAlert @myESMO @_SEOM @ASCO

DrMirallas's tweet image. #ESMO25 #drugdevelopment 👉🏽 Botensilimab (CTLA4) + Balstilimab (PD1) 🗣️ Dr. Gordon 👥 Pantumor cold tumors and PD1 r/r ✅ ORR 17% ✅ 411 patients ✅ Durable responses in 🥶tumors ☣️ 10% =>G3 colitis @OncoAlert @myESMO @_SEOM @ASCO
DrMirallas's tweet image. #ESMO25 #drugdevelopment 👉🏽 Botensilimab (CTLA4) + Balstilimab (PD1) 🗣️ Dr. Gordon 👥 Pantumor cold tumors and PD1 r/r ✅ ORR 17% ✅ 411 patients ✅ Durable responses in 🥶tumors ☣️ 10% =>G3 colitis @OncoAlert @myESMO @_SEOM @ASCO
DrMirallas's tweet image. #ESMO25 #drugdevelopment 👉🏽 Botensilimab (CTLA4) + Balstilimab (PD1) 🗣️ Dr. Gordon 👥 Pantumor cold tumors and PD1 r/r ✅ ORR 17% ✅ 411 patients ✅ Durable responses in 🥶tumors ☣️ 10% =>G3 colitis @OncoAlert @myESMO @_SEOM @ASCO
DrMirallas's tweet image. #ESMO25 #drugdevelopment 👉🏽 Botensilimab (CTLA4) + Balstilimab (PD1) 🗣️ Dr. Gordon 👥 Pantumor cold tumors and PD1 r/r ✅ ORR 17% ✅ 411 patients ✅ Durable responses in 🥶tumors ☣️ 10% =>G3 colitis @OncoAlert @myESMO @_SEOM @ASCO
0
10
13
2
1K
DrMirallas's profile picture. Fellow @MDAndersonNews | Medical Oncol, Drug Develop+🫁 23-25 @VHIO | Med Oncology 18-23 @vallhebron | Vocal Junta 21-25 @COMBarcelona Profesor 18-25 @SalutUIC
Oriol Mirallas MD
 @DrMirallas
Oct 17

#ESMO25 🚨 FIRST of my #Top10 #drugdevelopment 👉🏽 EVX-01 (vaccine) + Pembro 🗣️ @AdnanKhattakOnc 👥 Melanoma r/R PD-1/PD-L1 ✔️ ORR 75% w/92% sustained response at 24m❗ ✅ 81% vaccine neoantigens ✅ 100% vaccine induced T cells ☣️ ❌ Missing #tox @OncoAlert @myESMO @_SEOM @ASCO

DrMirallas's tweet image. #ESMO25 🚨 FIRST of my #Top10 #drugdevelopment 👉🏽 EVX-01 (vaccine) + Pembro 🗣️ @AdnanKhattakOnc 👥 Melanoma r/R PD-1/PD-L1 ✔️ ORR 75% w/92% sustained response at 24m❗ ✅ 81% vaccine neoantigens ✅ 100% vaccine induced T cells ☣️ ❌ Missing #tox @OncoAlert @myESMO @_SEOM @ASCO
DrMirallas's tweet image. #ESMO25 🚨 FIRST of my #Top10 #drugdevelopment 👉🏽 EVX-01 (vaccine) + Pembro 🗣️ @AdnanKhattakOnc 👥 Melanoma r/R PD-1/PD-L1 ✔️ ORR 75% w/92% sustained response at 24m❗ ✅ 81% vaccine neoantigens ✅ 100% vaccine induced T cells ☣️ ❌ Missing #tox @OncoAlert @myESMO @_SEOM @ASCO
DrMirallas's tweet image. #ESMO25 🚨 FIRST of my #Top10 #drugdevelopment 👉🏽 EVX-01 (vaccine) + Pembro 🗣️ @AdnanKhattakOnc 👥 Melanoma r/R PD-1/PD-L1 ✔️ ORR 75% w/92% sustained response at 24m❗ ✅ 81% vaccine neoantigens ✅ 100% vaccine induced T cells ☣️ ❌ Missing #tox @OncoAlert @myESMO @_SEOM @ASCO
DrMirallas's tweet image. #ESMO25 🚨 FIRST of my #Top10 #drugdevelopment 👉🏽 EVX-01 (vaccine) + Pembro 🗣️ @AdnanKhattakOnc 👥 Melanoma r/R PD-1/PD-L1 ✔️ ORR 75% w/92% sustained response at 24m❗ ✅ 81% vaccine neoantigens ✅ 100% vaccine induced T cells ☣️ ❌ Missing #tox @OncoAlert @myESMO @_SEOM @ASCO
3
6
19
1
2K
Certara's profile picture. Accelerating medicines to patients with biosimulation, technology and services.
Certara
 @Certara
Oct 22

With 200+ years of combined expertise, Certara’s Simcyp team leads the way in PBPK science—driving 125+ FDA approvals, EMA qualification, and global regulatory trust. See how Simcyp accelerates safer, smarter drug development: ow.ly/yVsu50X85I6 #PBPK #DrugDevelopment

Certara's tweet image. With 200+ years of combined expertise, Certara’s Simcyp team leads the way in PBPK science—driving 125+ FDA approvals, EMA qualification, and global regulatory trust. See how Simcyp accelerates safer, smarter drug development: ow.ly/yVsu50X85I6 #PBPK #DrugDevelopment
0
0
2
0
56
PiramalPharma's profile picture. Piramal Pharma Solutions is the contract development and manufacturing (CDMO) division of Piramal Group, offering services across the entire drug-cycle.
Piramal Pharma Solutions
 @PiramalPharma
Sep 5

Unlock the potential of HPAPIs in oncology. With safety-first manufacturing, peptide API expertise & seamless scale-up, Piramal Pharma Solutions advances your oncology pipeline with confidence. Read our blog: piramalpharmasolutions.com/resources/blog… #HPAPI #Oncology #DrugDevelopment #CDMO

PiramalPharma's tweet image. Unlock the potential of HPAPIs in oncology. With safety-first manufacturing, peptide API expertise & seamless scale-up, Piramal Pharma Solutions advances your oncology pipeline with confidence. Read our blog: piramalpharmasolutions.com/resources/blog… #HPAPI #Oncology #DrugDevelopment #CDMO
0
0
4
0
215
omalirp's profile picture. Medical Oncologist 🩺 🇦🇺
Omali Pitiyarachchi
 @omalirp
Jul 17

Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma

omalirp's tweet image. Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma
omalirp's tweet image. Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma
0
2
13
0
524
DDWJournal's profile picture. The Global Business Review of Drug Discovery and Development
Drug Discovery World
 @DDWJournal
Sep 25

Can human mini-Hearts advance cardiovascular drug development? ddw-online.com/how-human-mini… Follow DDW; Business insights for the global scientific community #DrugDevelopment

DDWJournal's tweet image. Can human mini-Hearts advance cardiovascular drug development? ddw-online.com/how-human-mini… Follow DDW; Business insights for the global scientific community #DrugDevelopment
1
2
2
0
127
Catalent_'s profile picture. Championing the missions that matter™. From development to delivery, we help pharma, biotech & consumer health companies transform lives.
Catalent
 @Catalent_
Oct 13

We’re heading to #AAPS2025! Swing by booth 2917 and see how we’re advancing drug development with cutting-edge formulation technologies and predictive modeling. Schedule a meeting with us: ow.ly/4EGI50XatMn #DrugDevelopment

0
0
0
0
133
herbloong's profile picture. Academic medical oncologist @ Hong Kong w/ interests in sarcoma medical oncology, thoracic oncology & phase 1 trials | Disclosures: https://t.co/sb5XXrv5zx
Herbert Loong, MBBS, FASCO
@herbloong
Oct 19

#Oncology #drugdevelopment is a wonderful journey. This cannot be done without #likeminded and #collaborative colleagues from around the World. There are only a few compounds that I've been involved in from the very beginning - #sevabertinib, together with #selpercatinib are 2…

herbloong's tweet image. #Oncology #drugdevelopment is a wonderful journey. This cannot be done without #likeminded and #collaborative colleagues from around the World. There are only a few compounds that I've been involved in from the very beginning - #sevabertinib, together with #selpercatinib are 2…
0
3
17
1
672
tmprowell's profile picture. Oncologist serving people w/ #cancer in #MedEd #SciComm & #bcsm. Past ASCO Ed Chair. Cofounder @HCWvsHunger. #LongCovid. Team hope/good trouble/go high. No FCOI
Tatiana Prowell, MD
 @tmprowell
Aug 28

‼️ Interested in use of registries for #oncology #DrugDevelopment & #regulatory decision-making? Or in pediatric #braintumor DMG/#DIPG? This is for you! Day 2 of free virtual public workshop: Th 8/28 10a-1p EDT. #ayacsm #btsm #raretumors #MedTwitter Link to register ⬇️ in 🧵

tmprowell's tweet image. ‼️ Interested in use of registries for #oncology #DrugDevelopment & #regulatory decision-making? Or in pediatric #braintumor DMG/#DIPG? This is for you! Day 2 of free virtual public workshop: Th 8/28 10a-1p EDT. #ayacsm #btsm #raretumors #MedTwitter Link to register ⬇️ in 🧵
2
2
10
1
2K
CPathInstitute's profile picture. C-Path leads collaborations that accelerate drug development, advancing better treatment for people worldwide.
Critical Path Institute (C-Path)
 @CPathInstitute
4 m

In 2025, C-Path proudly celebrates 20 years of impact. Take a look back at the highlights and the incredible individuals who made it all possible. Here's to the next chapter of innovation! f.mtr.cool/lglzgvzfjq #CPath20Years #DrugDevelopment #Collaboration

0
0
0
0
6
CPathInstitute's profile picture. C-Path leads collaborations that accelerate drug development, advancing better treatment for people worldwide.
Critical Path Institute (C-Path)
 @CPathInstitute
2 h

Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: f.mtr.cool/edcqhezbhi

CPathInstitute's tweet image. Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: f.mtr.cool/edcqhezbhi
0
0
0
0
17
HealthSkyAcad's profile picture. Empowering Medical professionals with premier medical and scientific education. https://t.co/l1FTbX4O11
Sky Health Academy
@HealthSkyAcad
7 h

From target identification to clinical trials — every breakthrough medicine follows a defined journey. Learn the five key stages of modern drug discovery. 👉 youtu.be/SLS2C6uPxSA #DrugDevelopment #PharmaceuticalIndustry #SkyHealthAcademy

HealthSkyAcad's tweet image. From target identification to clinical trials — every breakthrough medicine follows a defined journey. Learn the five key stages of modern drug discovery. 👉 youtu.be/SLS2C6uPxSA #DrugDevelopment #PharmaceuticalIndustry #SkyHealthAcademy
0
0
0
0
1
CPathInstitute's profile picture. C-Path leads collaborations that accelerate drug development, advancing better treatment for people worldwide.
Critical Path Institute (C-Path)
 @CPathInstitute
Nov 6

Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: f.mtr.cool/nbhtkiwlsp

CPathInstitute's tweet image. Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: f.mtr.cool/nbhtkiwlsp
0
0
0
0
15
Scientist_Live1's profile picture. Established in 2002 Scientist Live brings you news on the Pharmaceutical, Food and Beverage, Chemical, Cosmetic, Medical and Biotechnology sectors.
Scientist_Live
 @Scientist_Live1
Nov 6

Abzena and Mabqi form strategic partnership to provide drug development solution Read more here: bit.ly/47YHEbM Subscribe to our weekly newsletter for the latest news delivered to your inbox: scientistlive.com/content/newsbr… #science #pharma #drugdevelopment

Scientist_Live1's tweet image. Abzena and Mabqi form strategic partnership to provide drug development solution Read more here: bit.ly/47YHEbM Subscribe to our weekly newsletter for the latest news delivered to your inbox: scientistlive.com/content/newsbr… #science #pharma #drugdevelopment
0
0
1
0
6
Certara's profile picture. Accelerating medicines to patients with biosimulation, technology and services.
Certara
 @Certara
Nov 6

Heading to AAPS 2025 PharmSci 360? Stop by booth #3458 for live Phoenix & Simcyp demos, expert insights, and the latest in model-informed drug development. Schedule a meeting: ow.ly/yhAp50XmzUR #PharmSci360 #DrugDevelopment

Certara's tweet image. Heading to AAPS 2025 PharmSci 360? Stop by booth #3458 for live Phoenix & Simcyp demos, expert insights, and the latest in model-informed drug development. Schedule a meeting: ow.ly/yhAp50XmzUR #PharmSci360 #DrugDevelopment
0
0
1
0
38
d__risk's profile picture. Monitoring Changes in Risk Factors - AI enabled
dRisk
@d__risk
Nov 6

$CGEM - Cullinan Therapeutics Inc. Common Stock - 10Q - Updated Risk Factors CGEM warns that challenges enrolling patients have delayed trials and could further stall or block clinical progress and regulatory approvals. #Biotechnology #DrugDevelopment #PatientEnrollment…

d__risk's tweet image. $CGEM - Cullinan Therapeutics Inc. Common Stock - 10Q - Updated Risk Factors CGEM warns that challenges enrolling patients have delayed trials and could further stall or block clinical progress and regulatory approvals. #Biotechnology #DrugDevelopment #PatientEnrollment…
0
0
1
0
159
ThegreatHuaofCN's profile picture. Just your everyday ABC...
The.great.Hua.of.china
 @ThegreatHuaofCN
Nov 6

Building a $1.2B factory for a drug that isn't even approved yet? Eli Lilly is betting big on its oral weight-loss pill, expanding its Puerto Rico plant before the FDA gives the green light. A bold move in a very crowded race. #Pharma #Biotech #DrugDevelopment

0
0
0
0
24
NASEM_Health's profile picture. We help leaders in government and the private sector make evidence-based decisions on health policy and practice.
NASEM Health
 @NASEM_Health
Nov 6

How can #AI transform #RegenerativeMedicine? Join us 11/18 for a hybrid workshop exploring how AI can enhance the translation of regenerative medicine therapies through its role in #DrugDevelopment, #ClinicalTrials, & biomanufacturing: ow.ly/rMI350X9X8E #RegenMedForum

NASEM_Health's tweet image. How can #AI transform #RegenerativeMedicine? Join us 11/18 for a hybrid workshop exploring how AI can enhance the translation of regenerative medicine therapies through its role in #DrugDevelopment, #ClinicalTrials, & biomanufacturing: ow.ly/rMI350X9X8E #RegenMedForum
0
0
0
0
148
GENbio's profile picture. Serving the biotech industry since 1981. EIC @johnsterling4; publisher @liebertpub Subscribe to GEN: https://t.co/KzqMccOt9Q
Genetic Engineering & Biotechnology News
 @GENbio
Nov 6

Unlock new possibilities in biomedical research! Discover how Optimers are transforming science in the FREE eBook from @AptamerGroup: hubs.li/Q03R1S0-0 #Antibodies #Optimers #DrugDevelopment

GENbio's tweet image. Unlock new possibilities in biomedical research! Discover how Optimers are transforming science in the FREE eBook from @AptamerGroup: hubs.li/Q03R1S0-0 #Antibodies #Optimers #DrugDevelopment
0
0
4
0
436
DrMirallas's profile picture. Fellow @MDAndersonNews | Medical Oncol, Drug Develop+🫁 23-25 @VHIO | Med Oncology 18-23 @vallhebron | Vocal Junta 21-25 @COMBarcelona Profesor 18-25 @SalutUIC
Oriol Mirallas MD
 @DrMirallas
Oct 15

#ESMO2025 Berlin is SOON here 🇩🇪 🚀 My #Top10 for #drugdevelopment @myESMO Interesting new drugs coming out 🙌🏽 🧫 CAR-T 💉 ADC 🦠 Vaccines 🧪 New#ICIs 🎯 #therapies @ASCO @_SEOM @VHIO @MDAndersonNews @OncBrothers 🌍 Follow: #OncoAlertAF @OncoAlert What do you think? 💭👇🏽

DrMirallas's tweet image. #ESMO2025 Berlin is SOON here 🇩🇪 🚀 My #Top10 for #drugdevelopment @myESMO Interesting new drugs coming out 🙌🏽 🧫 CAR-T 💉 ADC 🦠 Vaccines 🧪 New#ICIs 🎯 #therapies @ASCO @_SEOM @VHIO @MDAndersonNews @OncBrothers 🌍 Follow: #OncoAlertAF @OncoAlert What do you think? 💭👇🏽
0
23
73
26
8K
FinQuota's profile picture. Stay ahead in the world of finance with FinQuota. #Finance #Investing #MarketAnalysis #Stocks
FinQuota
@FinQuota
Oct 6

Is CRBP stock just practicing its yoga poses with all these ups and downs? Source: finquota.com/CRBP/ #StockMarket #DrugDevelopment #ClinicalTrials #NYSE #stock #stocks

FinQuota's tweet image. Is CRBP stock just practicing its yoga poses with all these ups and downs? Source: finquota.com/CRBP/ #StockMarket #DrugDevelopment #ClinicalTrials #NYSE #stock #stocks
0
2
7
0
49
NeulandLabs's profile picture. Neuland Labs is a leading manufacturer of active pharmaceutical ingredients (APIs) and a chemistry solutions provider to the pharmaceutical industry.
NeulandLabs
 @NeulandLabs
Oct 27

Every stage of drug development benefits from the right expertise. Explore how choosing between a CDMO, CMO, or CRO can define your project’s progress in our new blog. Read the full article here: hubs.la/Q03Q9lx-0 #NeulandLabs #CDMO #DrugDevelopment #Outsourcing

NeulandLabs's tweet image. Every stage of drug development benefits from the right expertise. Explore how choosing between a CDMO, CMO, or CRO can define your project’s progress in our new blog. Read the full article here: hubs.la/Q03Q9lx-0 #NeulandLabs #CDMO #DrugDevelopment #Outsourcing
1
0
4
0
316
AJNadabo's profile picture. An inquisitive minded Drug Scientist| Logistician| Drug Development| Global Health| Vaccinology
Abduljalal Nadabo (RPh)
 @AJNadabo
May 26

Pretty intense May. #Vaccinology 💉 #DrugDevelopment 💊 #MVDD #UniSi

AJNadabo's tweet image. Pretty intense May. #Vaccinology 💉 #DrugDevelopment 💊 #MVDD #UniSi
AJNadabo's tweet image. Pretty intense May. #Vaccinology 💉 #DrugDevelopment 💊 #MVDD #UniSi
AJNadabo's tweet image. Pretty intense May. #Vaccinology 💉 #DrugDevelopment 💊 #MVDD #UniSi
AJNadabo's tweet image. Pretty intense May. #Vaccinology 💉 #DrugDevelopment 💊 #MVDD #UniSi
mvcciido_szn's profile picture. future BILLIONAIRE | Like 7 niggas be using this account | 🚩| Business 📩 | PARODY | NPC | ١ of ١ | URBAN PLANNER | Auto concierge.
🛸
@mvcciido_szn
May 25

may dump ?

357
274
2K
2K
23.8M
3
17
69
2
4K
ncats_nih_gov's profile picture. Official account. https://t.co/E0jyoPAqWA https://t.co/5jpXb0jIER engagement ≠ endorsement
NCATS
@ncats_nih_gov
Sep 23

For over 10 years, we have made #DrugDiscovery & development steps faster & more predictable. Using what we’ve learned, we create educational resources to share this information with the #TranslationalScience community. To improve understanding of the complex #DrugDevelopment &…

ncats_nih_gov's tweet image. For over 10 years, we have made #DrugDiscovery & development steps faster & more predictable. Using what we’ve learned, we create educational resources to share this information with the #TranslationalScience community. To improve understanding of the complex #DrugDevelopment &…
ncats_nih_gov's tweet image. For over 10 years, we have made #DrugDiscovery & development steps faster & more predictable. Using what we’ve learned, we create educational resources to share this information with the #TranslationalScience community. To improve understanding of the complex #DrugDevelopment &…
0
2
6
1
542
PiramalPharma's profile picture. Piramal Pharma Solutions is the contract development and manufacturing (CDMO) division of Piramal Group, offering services across the entire drug-cycle.
Piramal Pharma Solutions
 @PiramalPharma
Sep 5

Unlock the potential of HPAPIs in oncology. With safety-first manufacturing, peptide API expertise & seamless scale-up, Piramal Pharma Solutions advances your oncology pipeline with confidence. Read our blog: piramalpharmasolutions.com/resources/blog… #HPAPI #Oncology #DrugDevelopment #CDMO

PiramalPharma's tweet image. Unlock the potential of HPAPIs in oncology. With safety-first manufacturing, peptide API expertise & seamless scale-up, Piramal Pharma Solutions advances your oncology pipeline with confidence. Read our blog: piramalpharmasolutions.com/resources/blog… #HPAPI #Oncology #DrugDevelopment #CDMO
0
0
4
0
215
JiaJennyLiu's profile picture. Early Phase Trials Medical Onc Translational Researcher @kinghorncancer SVH Sydney @CMRI Senior Lecturer @UNSW. MOGA Exec. #PrecisionMedicine #drugdevelopment
Jia (Jenny) Liu MD PhD
 @JiaJennyLiu
Oct 27

Totally agree @curijoey - taking a post-#ESMO25 recovery pause in your beautiful home country 🇮🇹 🍷🫒⛪️ at the moment… before return to #drugdevelopment rat race! 🇦🇺

JiaJennyLiu's tweet image. Totally agree @curijoey - taking a post-#ESMO25 recovery pause in your beautiful home country 🇮🇹 🍷🫒⛪️ at the moment… before return to #drugdevelopment rat race! 🇦🇺
JiaJennyLiu's tweet image. Totally agree @curijoey - taking a post-#ESMO25 recovery pause in your beautiful home country 🇮🇹 🍷🫒⛪️ at the moment… before return to #drugdevelopment rat race! 🇦🇺
curijoey's profile picture. Giuseppe Curigliano, MD, PhD, Professor at University of Milan and Head of Phase I Division at IEO, ESMO Open EiC, Tweets are my own
G Curigliano MD PhD
 @curijoey
Oct 26

Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿

curijoey's tweet image. Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿
curijoey's tweet image. Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿
curijoey's tweet image. Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿
curijoey's tweet image. Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿
4
6
146
2
8K
1
1
8
0
2K
MIMETAS_3D's profile picture. As an organ-on-a-chip pioneer, MIMETAS develops any-throughput 3D human tissue and disease models in OrganoPlates®.
MIMETAS
 @MIMETAS_3D
Sep 29

GI toxicity is a major side effect of cancer therapies. Our 3D Colon Organoid Model brings human relevance + high-throughput screening to better predict drug-induced GI toxicity. Explore our poster 👉 shorturl.at/8APaR #Toxicology #Organoids #DrugDevelopment #Innovation

MIMETAS_3D's tweet image. GI toxicity is a major side effect of cancer therapies. Our 3D Colon Organoid Model brings human relevance + high-throughput screening to better predict drug-induced GI toxicity. Explore our poster 👉 shorturl.at/8APaR #Toxicology #Organoids #DrugDevelopment #Innovation
0
0
2
1
97
medicine_maker's profile picture. Exploring the human side of drug manufacturing & development 💊 Send your news, opinions, and stories @SJC_Sutton
The Medicine Maker
 @medicine_maker
Oct 23

⏳ Last chance! 2025 Innovation Awards nominations close Nov 7. Free to enter. Big visibility. ✅ Pharma & biopharma tech launched Nov 2024–Dec 2025 👉 Submit now: ow.ly/HLbX50X1qFA #Pharma #Biotech #DrugDevelopment #CGT #Innovation

medicine_maker's tweet image. ⏳ Last chance! 2025 Innovation Awards nominations close Nov 7. Free to enter. Big visibility. ✅ Pharma & biopharma tech launched Nov 2024–Dec 2025 👉 Submit now: ow.ly/HLbX50X1qFA #Pharma #Biotech #DrugDevelopment #CGT #Innovation
0
0
0
0
37
Catalent_'s profile picture. Championing the missions that matter™. From development to delivery, we help pharma, biotech & consumer health companies transform lives.
Catalent
 @Catalent_
Oct 22

Join us in Frankfurt as our experts share how cutting-edge science, automation, and advanced platforms are transforming development and supply! 👉 Schedule a 1:1 meeting with our team and explore what’s next for your mission: ow.ly/6SY050Xgji2 #CPHI2025 #DrugDevelopment

Catalent_'s tweet image. Join us in Frankfurt as our experts share how cutting-edge science, automation, and advanced platforms are transforming development and supply! 👉 Schedule a 1:1 meeting with our team and explore what’s next for your mission: ow.ly/6SY050Xgji2 #CPHI2025 #DrugDevelopment
0
0
0
0
82
editorNRTimes's profile picture. NR Times, the neurorehabilitation platform covering brain and spinal injuries and neuro conditions from every angle. Sign-up & subscribe online.
Neuro Rehab Times
@editorNRTimes
Oct 27

BioNxt has launched a 15-day dosing optimisation study for its sublingual multiple sclerosis (MS) drug, marking the final step before human bioequivalence testing planned for early 2026. 🔗 Full story: buff.ly/gPjwCF7 #MultipleSclerosis #NeuroResearch #DrugDevelopment…

editorNRTimes's tweet image. BioNxt has launched a 15-day dosing optimisation study for its sublingual multiple sclerosis (MS) drug, marking the final step before human bioequivalence testing planned for early 2026. 🔗 Full story: buff.ly/gPjwCF7 #MultipleSclerosis #NeuroResearch #DrugDevelopment…
0
0
2
0
99
Catalent_'s profile picture. Championing the missions that matter™. From development to delivery, we help pharma, biotech & consumer health companies transform lives.
Catalent
 @Catalent_
Sep 24

Thank you to everyone who attended our recent seminar in Copenhagen! We had an incredible time connecting with innovators across the life sciences community to explore strategies for de-risking emerging new chemical modalities. #MVA #DrugDevelopment #PharmaInnovation

Catalent_'s tweet image. Thank you to everyone who attended our recent seminar in Copenhagen! We had an incredible time connecting with innovators across the life sciences community to explore strategies for de-risking emerging new chemical modalities. #MVA #DrugDevelopment #PharmaInnovation
Catalent_'s tweet image. Thank you to everyone who attended our recent seminar in Copenhagen! We had an incredible time connecting with innovators across the life sciences community to explore strategies for de-risking emerging new chemical modalities. #MVA #DrugDevelopment #PharmaInnovation
Catalent_'s tweet image. Thank you to everyone who attended our recent seminar in Copenhagen! We had an incredible time connecting with innovators across the life sciences community to explore strategies for de-risking emerging new chemical modalities. #MVA #DrugDevelopment #PharmaInnovation
Catalent_'s tweet image. Thank you to everyone who attended our recent seminar in Copenhagen! We had an incredible time connecting with innovators across the life sciences community to explore strategies for de-risking emerging new chemical modalities. #MVA #DrugDevelopment #PharmaInnovation
0
0
0
0
87
QIAGENBiox's profile picture. QIAGEN Digital Insights (Ingenuity, CLC bio, BIOBASE and OmicSoft) integrates and streamlines solutions to the benefits of our users in bioinformatics spaces.
QIAGEN Digital Insights
 @QIAGENBiox
Sep 8

Final call: Dr. George Church will be speaking about how DNA sequencing is becoming more accessible, transforming #drugdevelopment for #precisionmedicine. Join our next Genomics for Health webinar tomorrow 👉 event.on24.com/wcc/r/5025154/…

QIAGENBiox's tweet image. Final call: Dr. George Church will be speaking about how DNA sequencing is becoming more accessible, transforming #drugdevelopment for #precisionmedicine. Join our next Genomics for Health webinar tomorrow 👉 event.on24.com/wcc/r/5025154/…
0
0
0
0
82
DDWJournal's profile picture. The Global Business Review of Drug Discovery and Development
Drug Discovery World
 @DDWJournal
Sep 25

Can human mini-Hearts advance cardiovascular drug development? ddw-online.com/how-human-mini… Follow DDW; Business insights for the global scientific community #DrugDevelopment

DDWJournal's tweet image. Can human mini-Hearts advance cardiovascular drug development? ddw-online.com/how-human-mini… Follow DDW; Business insights for the global scientific community #DrugDevelopment
1
2
2
0
127
tmprowell's profile picture. Oncologist serving people w/ #cancer in #MedEd #SciComm & #bcsm. Past ASCO Ed Chair. Cofounder @HCWvsHunger. #LongCovid. Team hope/good trouble/go high. No FCOI
Tatiana Prowell, MD
 @tmprowell
Aug 28

‼️ Interested in use of registries for #oncology #DrugDevelopment & #regulatory decision-making? Or in pediatric #braintumor DMG/#DIPG? This is for you! Day 2 of free virtual public workshop: Th 8/28 10a-1p EDT. #ayacsm #btsm #raretumors #MedTwitter Link to register ⬇️ in 🧵

tmprowell's tweet image. ‼️ Interested in use of registries for #oncology #DrugDevelopment & #regulatory decision-making? Or in pediatric #braintumor DMG/#DIPG? This is for you! Day 2 of free virtual public workshop: Th 8/28 10a-1p EDT. #ayacsm #btsm #raretumors #MedTwitter Link to register ⬇️ in 🧵
2
2
10
1
2K
DDWJournal's profile picture. The Global Business Review of Drug Discovery and Development
Drug Discovery World
 @DDWJournal
Oct 20

Quality drug candidates in under 2 years November 10, 8 am PST / 11 am EST / 4 pm GMT / 5 pm CET Register here now! attendee.gotowebinar.com/register/84853… Follow DDW; Business insights for the global scientific community Supported by @Evotec #DrugDevelopment

DDWJournal's tweet image. Quality drug candidates in under 2 years November 10, 8 am PST / 11 am EST / 4 pm GMT / 5 pm CET Register here now! attendee.gotowebinar.com/register/84853… Follow DDW; Business insights for the global scientific community Supported by @Evotec #DrugDevelopment
0
1
1
0
404
omalirp's profile picture. Medical Oncologist 🩺 🇦🇺
Omali Pitiyarachchi
 @omalirp
Jul 17

Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma

omalirp's tweet image. Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma
omalirp's tweet image. Prof Loong with an engaging talk on patient selection-genomic matching, handling NGS big data, and considering intratumoural heterogeneity - Day 1 @myesmo Advanced Course on #DrugDevelopment in Hong Kong / session chaired by Prof Jayesh Desai & Prof Brigette Ma
0
2
13
0
524
QIAGENBiox's profile picture. QIAGEN Digital Insights (Ingenuity, CLC bio, BIOBASE and OmicSoft) integrates and streamlines solutions to the benefits of our users in bioinformatics spaces.
QIAGEN Digital Insights
 @QIAGENBiox
Sep 3

DNA sequencing? In this economy? Yes, precisely because of the current economy. 💸 Learn how the increasing accessibility of #DNAsequencing is changing the #drugdevelopment game and slashing drug prices. Join us on Sept. 9 👉 event.on24.com/wcc/r/5025154/…

QIAGENBiox's tweet image. DNA sequencing? In this economy? Yes, precisely because of the current economy. 💸 Learn how the increasing accessibility of #DNAsequencing is changing the #drugdevelopment game and slashing drug prices. Join us on Sept. 9 👉 event.on24.com/wcc/r/5025154/…
0
0
1
0
50

Something went wrong.


Something went wrong.


United States Trends